4D Molecular Therapeutics (FDMT) Q2 2025 Earnings

May 8Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.89
-0.8
-0.72
-0.63

Details

Expected EPS
-0.87076
Actual EPS
-0.86
Surprise EPS
0.01
Surprise Percent
+1.24%

Description

⁨4D Molecular Therapeutics⁩ (⁦FDMT⁩) has reported earnings of ⁦-0.86⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts